ImmuPharma is a pharmaceutical company focused on developing innovative drugs to treat serious medical conditions in specialist therapeutic areas. Its low risk-strategy is to work closely with the largest fundamental research institutions, which allows access to scientists and doctors, keeping costs low by avoiding the constant funding necessary for early-stage research. The Company offers Lupuzor, a treatment for Lupus and its most advanced drug candidate.